pimonidazole
Commercial- Indications
- Research use
Company intelligence / Profile preview
Hypoxyprobe
Burlington, Massachusetts, United Statespmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Hypoxyprobe’s pimonidazole-based kits are widely used in preclinical and clinical research to detect tissue hypoxia. The technology has been referenced in over 500 publications and adopted by pharmaceutical companies as a companion marker in clinical trials of hypoxia-targeted therapies[2][3][8].
- Therapeutic areas
- OncologyOther
- Modalities
- Small moleculeAntibody
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
1 asset03
Partnerships
Chemicon InternationalUniversity of North Carolina at Chapel Hill
Beyond the preview
Go deeper on Hypoxyprobe.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hypoxyprobe.